F39-32786-05142
4 vaccinations
6 coded responses
25 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 308 / GA
- Registered
- 2021-12-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-15
Dose 1 — Moderna
-
2021-06-14
Dose 2 — Moderna
-
2021-12-23
Dose 3 — Moderna
-
2021-12-24
Registered in v-safe
-
2021-12-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-25
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-26
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-27
Health check-in — days 1–6 daily, dose 3Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-28
Health check-in — days 1–6 daily, dose 3Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-12-30
Health check-in — day 7, dose 3Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2022-01-06
Survey response — day 14, dose 3MedDRA: Arthralgia, Fatigue, Nasal discomfort, Neck pain, Throat irritation — Feeling: FairFree text: Fatigue, aching shoulders and neck, minor scratchy throat, and nasal irritations.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Survey response — day 21, dose 3MedDRA: Arthralgia, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Headaches worse and joint pain increased.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-20
- 2022-01-27
- 2022-02-03
- 2022-03-24
-
2022-05-07
Dose 4 — Moderna
- 2022-05-07
-
2022-05-09
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-10
Health check-in — days 1–6 daily, dose 4Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-11
Health check-in — days 1–6 daily, dose 4Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-12
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Joint pains, Muscle or body achesAdult check-in
-
2022-05-14
Health check-in — day 7, dose 4Feeling: Fair · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
- 2022-05-21
-
2022-05-29
Survey response — day 21, dose 4MedDRA: Dehydration, Dizziness, Hypersensitivity — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Occasional dizziness, sensitivity to allergies not previously an issue, inability to maintain hydration even though I drink water throughout the day.MedDRA releases: 2024-11 · check-in free text available
- 2022-06-04
-
2022-06-11
Survey response — day 35, dose 4MedDRA: Chest discomfort, Migraine, Sinus disorder, Visual impairment — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Extremely heavy chest, severe sinus issues, more frequent migraines, and vision changes periodically.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-18
Survey response — day 42, dose 4MedDRA: Lethargy, Sleep deficit, Somnolence — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Severely lethargic - feeling sleep deprived, to the point where I have to fight to keep my eyes opened, in the afternoon hours.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-06
Survey response — 3 months, dose 4MedDRA: Dizziness, Medical procedure, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Dizzy spell that lasted three days. Have already had one investigative medical procedure, and have another one scheduled for next week. · Healthcare visit (other): Doppler imagingMedDRA releases: 2024-11 · check-in free text available
-
2022-08-06
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-08-10
Call successfulCompleted over the phone
- 2022-11-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-15 | Moderna | No |
| 2 | 2021-06-14 | Moderna | No |
| 3 | 2021-12-23 | Moderna | No |
| 4 | 2022-05-07 | Moderna | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 10 — day 14, dose 3
Symptoms: Fatigue, aching shoulders and neck, minor scratchy throat, and nasal irritations.
Release 10 — day 21, dose 3
Symptoms: Headaches worse and joint pain increased.
Release 11 — day 21, dose 4
Symptoms: Occasional dizziness, sensitivity to allergies not previously an issue, inability to maintain hydration even though I drink water throughout the day.
Release 12 — day 35, dose 4
Symptoms: Extremely heavy chest, severe sinus issues, more frequent migraines, and vision changes periodically.
Release 12 — day 42, dose 4
Symptoms: Severely lethargic - feeling sleep deprived, to the point where I have to fight to keep my eyes opened, in the afternoon hours.
Release 12 — 3 months, dose 4
Symptoms: Dizzy spell that lasted three days. Have already had one investigative medical procedure, and have another one scheduled for next week.
Healthcare visit (other): Doppler imaging
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Chest discomfort | · | · | ✓ |
| SD | Dehydration | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Medical procedure | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nasal discomfort | · | · | ✓ |
| SD | Neck pain | · | · | ✓ |
| SD | Sinus disorder | · | · | ✓ |
| SD | Sleep deficit | · | · | ✓ |
| SD | Somnolence | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release